共 50 条
TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription
被引:65
|作者:
Kawarada, Yuki
[1
]
Inoue, Yasumichi
[1
,2
]
Kawasaki, Fumihiro
[1
]
Fukuura, Keishi
[1
]
Sato, Koichi
[1
]
Tanaka, Takahito
[1
]
Itoh, Yuka
[1
,2
]
Hayashi, Hidetoshi
[1
,2
]
机构:
[1] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Cell Signaling, Nagoya, Aichi 4678603, Japan
[2] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Innovat Therapeut Sci, Cooperat Major Nanopharmaceut Sci, Nagoya, Aichi 4678603, Japan
来源:
基金:
日本学术振兴会;
关键词:
GROWTH-FACTOR-BETA;
EPITHELIAL-MESENCHYMAL TRANSITION;
TUMOR-SUPPRESSOR P53;
PLASMINOGEN-ACTIVATOR;
HUMAN CANCER;
SMAD;
TRISTETRAPROLIN;
PATHWAYS;
CELLS;
COACTIVATORS;
D O I:
10.1038/srep35483
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Transforming growth factor beta (TGF-beta) signaling facilitates tumor development during the advanced stages of tumorigenesis, but induces cell-cycle arrest for tumor suppression during the early stages. However, the mechanism of functional switching of TGF-beta is still unknown, and it is unclear whether inhibition of TGF-beta signaling results amelioration or exacerbation of cancers. Here we show that the tumor suppressor p53 cooperates with Smad proteins, which are TGF-beta signal transducers, to selectively activate plasminogen activator inhibitor type-1 (PAI-1) transcription. p53 forms a complex with Smad2/3 in the PAI-1 promoter to recruit histone acetyltransferase CREB-binding protein (CBP) and enhance histone H3 acetylation, resulting in transcriptional activation of the PAI-1 gene. Importantly, p53 is required for TGF-beta-induced cytostasis and PAI-1 is involved in the cytostatic activity of TGF-beta in several cell lines. Our results suggest that p53 enhances TGF-beta-induced cytostatic effects by activating PAI-1 transcription, and the functional switching of TGF-beta is partially caused by p53 mutation or p53 inactivation during cancer progression. It is expected that these findings will contribute to optimization of TGF-beta-targeting therapies for cancer.
引用
收藏
页数:13
相关论文